Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan 27:12:805695.
doi: 10.3389/fimmu.2021.805695. eCollection 2021.

An Update on Human Papilloma Virus Vaccines: History, Types, Protection, and Efficacy

Zahra Yousefi  1 , Hamid Aria  2 , Farhoodeh Ghaedrahmati  2 , Tahereh Bakhtiari  2 , Mahdieh Azizi  2 , Reza Bastan  3 , Reza Hosseini  2 , Nahid Eskandari  2
Affiliations
Review

An Update on Human Papilloma Virus Vaccines: History, Types, Protection, and Efficacy

Zahra Yousefi et al. Front Immunol. .

Abstract

Human papillomavirus (HPV) is the most common sexually transmitted agent worldwide. Early prevention with HPV vaccination is a safe and effective method against this disease. HPV vaccines provided more protection against several oncogenic HPV strains. Three prophylactic HPV vaccines have been approved to target high-risk HPV types and protect against HPV-related disorders. These existing vaccines are based on the recombinant DNA technology and purified L1 protein that is assembled to form HPV empty shells. The prophylactic vaccines are highly immunogenic and can induce production of specific neutralizing antibodies. However, therapeutic vaccines are different from these prophylactic vaccines. They induced cell-mediated immunity against transformed cells, instead of neutralizing antibodies. The second generation of prophylactic HPV vaccines, made from alternative viral components using cost-effective production strategies, is undergoing clinical evaluation. The purpose of this review is to provide a complete and up-to-date review of the types of HPV vaccines and the efficiency of each of them for readers.

Keywords: HPV vaccination; cervical cancer; human papillomavirus (HPV); prevalence; vaccines.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Pathogenesis of HPV infection. Initially, the virus was latent inside the epithelial cell and had a low proliferation rate. As the virus enters the lysogenic cycle, the rate of proliferation increases. Finally, the viruses are assembled and secreted from keratinocytes to repeat the infection cycle.
Figure 2
Figure 2
The natural HPV infection can lead to cervical cancer. The cervical intraepithelial neoplasia (CIN) scale is classified into CIN1 (mild dysplasia), CIN2 (moderate dysplasia), and CIN3 (severe dysplasia and carcinoma in situ).
Figure 3
Figure 3
The production mechanisms of prophylactic vaccines. Eukaryotic systems including Cervarix, Gardasil, and Gardasil-9 vaccines and prokaryotic systems including Cecolin and Gelcolin vaccines used against HPV and how to produce VLP are shown.
See this image and copyright information in PMC

References

    1. Perez-Campos Mayoral E, Mayoral-Andrade G, Pérez-Campos Mayoral L, Canseco SP, Cruz RM, Hernández-Huerta MT, et al. . Diagnosis of Transient/Latent HPV Infections - A Point of View! Arch Med Res (2018) 49(5):293–6. doi: 10.1016/j.arcmed.2018.10.004 - DOI
    1. Madrid-Marina V, Torres-Poveda K, López-Toledo G, García-Carrancá A. Advantages and Disadvantages of Current Prophylactic Vaccines Against HPV. Arch Med Res (2009) 40(6):471–7. doi: 10.1016/j.arcmed.2009.08.005 - DOI - PubMed
    1. Alaez-Verson C, Berumen-Campos J, Munguía-Saldaña A, Flores-Aguilar H, Guardado-Estrada M, Rodríguez-Gomez A, et al. . HPV-16 and HLA-DRB1 Alleles Are Associated With Cervical Carcinoma in Mexican Mestizo Women. Arch Med Res (2011) 42(5):421–5. doi: 10.1016/j.arcmed.2011.07.002 - DOI - PubMed
    1. Lizano M, Berumen J, García-Carrancá A. HPV-Related Carcinogenesis: Basic Concepts, Viral Types and Variants. Arch Med Res (2009) 40(6):428–34. doi: 10.1016/j.arcmed.2009.06.001 - DOI - PubMed
    1. de Sanjose S, Brotons M, Pavón MA. The Natural History of Human Papillomavirus Infection. Best Pract Res Clin Obstet Gynaecol (2018) 47:2–13. doi: 10.1016/j.bpobgyn.2017.08.015 - DOI - PubMed

MeSH terms

Substances